Detalhe da pesquisa
1.
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Blood
; 139(3): 413-423, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570876
2.
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Blood
; 137(3): 374-386, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663292
3.
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Am J Hematol
; 98(3): 464-471, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629030
4.
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Am J Hematol
; 98(2): 300-308, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588409
5.
Secondary Central Nervous System Lymphoma: Updates in Treatment and Prophylaxis Strategies.
Curr Treat Options Oncol
; 23(10): 1443-1456, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127571
6.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica
; 106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538152
7.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
8.
TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma.
Haematologica
; 108(11): 3110-3114, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226703
9.
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma.
Leuk Lymphoma
; 64(1): 107-118, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323309
10.
Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
J Clin Oncol
; 40(26): 3020-3031, 2022 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436146
11.
Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
Cancer Res Commun
; 2(12): 1684-1692, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644323
12.
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.
Blood Adv
; 5(18): 3623-3632, 2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448831
13.
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.
Blood Adv
; 5(14): 2852-2862, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283175
14.
Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia.
Curr Hematol Malig Rep
; 13(2): 100-108, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29442287
15.
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
Blood Adv
; 7(11): 2459-2462, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622349